Current Neurology and Neuroscience Reports

, Volume 5, Issue 1, pp 9–12 | Cite as

Prevention of embolism among patients with atrial fibrillation

  • Harold P. AdamsJr
Clinical Trials Report


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hart RG, Halperin JL: Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention. Ann Intern Med 1999, 131:492–501.PubMedGoogle Scholar
  2. 2.
    Albers GW, Amarenco P, Easton JD, et al.: Anithrombotic and thrombolytic therapy for ischemic stroke. Chest 2001, 119:300S-320S.PubMedCrossRefGoogle Scholar
  3. 3.
    Brass LM, Krumholz HM, Scinto JM, Radford M: Warfarin use among patients with atrial fibrillation. Stroke 1997, 28:2382–2389.PubMedGoogle Scholar
  4. 4.
    Harenberg J, Ingrid J, Tivadar F: Treatment of venous thromboemoblism with the oral thrombin inhibitor, ximelagatran. Israel Med Assoc J 2002, 4:1003–1005.Google Scholar
  5. 5.
    Eriksson BI, Bergqvist D, Kalebo P, et al.: Ximelagatran and melagaran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial. Lancet 2002, 360:1441–1447.PubMedCrossRefGoogle Scholar
  6. 6.
    Schulman S, Wahlander K, Lundstrom T, et al., for the THRIVE III Investigators: Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran. N Engl J Med 2003, 349:1713–1721.PubMedCrossRefGoogle Scholar
  7. 7.
    Executive Steering Committee on behalf of the SPORTIF III Investigators: Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with nonvalvular atrial fibrillation (SPORTIF III): randomised controlled trial. Lancet 2003, 362:1691–1698.CrossRefGoogle Scholar
  8. 8.
    Mohr JP, Thompson JP, Lazar RM, et al.: A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001, 345:1444–1451.PubMedCrossRefGoogle Scholar
  9. 9.
    Ezekowitz MD, Bridgers SL, James KE, et al.: Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med 1992, 327:1406–1412.PubMedCrossRefGoogle Scholar
  10. 10.
    Halperin JL; Executive Steering Committee, SPORTIF III and V Study Investigators: Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V). Am Heart J 2003, 146:431–438.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc. 2005

Authors and Affiliations

  • Harold P. AdamsJr

There are no affiliations available

Personalised recommendations